MEDICAL DEVICE REGULATIONS EVOLVE FOR AUSTRALIAN INNOVATORS WITH EUROPEAN AMBITIONS Notified body and approved body attend Regulatory Summit to support access to the EU market.
With
Gabrielle Cesvet,
Head of Public Affairs, Scarlet
Tirion Evans, Head of Technical Operations &
Head of Notified Body, Scarlet
SEGMENT
Filmed in Sydney | October 2026
Medical device regulation is undergoing significant change as regulators across major jurisdictions grapple with the rapid growth of software and artificial intelligence (AI) in healthcare.
Speaking with Australian Health Journal at the Medical Technology Association of Australia’s RegConnect Summit 2026 in Sydney in September, Gabrielle Cesvet, Head of Public Affairs at Scarlet, said manufacturers need greater clarity and sufficient lead time as new regulatory frameworks emerge.
“We need to make sure that from a regulatory perspective and from a conformity assessment perspective, we’re able to keep pace with that innovation,” she said.
Cesvet highlighted reforms underway in the European Union, including efforts to simplify the Medical Device Regulation (MDR), reduce regulatory burdens and create a framework better suited to software and AI. She also pointed to the UK’s plans to revamp its regulatory system and increase international reliance.
Tirion Evans, Head of Technical Operations and Head of Notified Body at Scarlet, said the company is increasingly working with Australian manufacturers seeking access to international markets. Scarlet operates as a Notified Body in the EU, an Approved Body in the UK and a Third Party Review Organization in the US.
Evans encouraged innovators to address regulatory requirements early rather than waiting until products are fully developed.
“The most important thing is to try and tackle the regulatory issues right at the beginning,” she said.
The interviews highlighted the growing importance of regulatory expertise in helping innovative software and AI medical devices reach markets efficiently while keeping pace with technological change.
- Source: Adapted from transcript using AI
- Media access credit: Medical Technology Association of Australia (MTAA), RegConnect Summit 2026, Sydney September, 2026
You Might also like
-
Implementing improvements in referral management and demand
Nalani Cox joined Gold Coast Health in 2019 as a Nurse Manager focused on improving referral management processes within the outpatient environment through the implementation of the Clinical Prioritisation Criteria. This work became a focus point for the organisation in 2020 when Nalani led an organisational wide change project introducing Smart Referrals, Refer Your Patient website and HealthPathways which has culminated in her position as the ADON of the Referral Strategy and Performance Department.
-
Digital tools help hospitals reduce missed appointments
Nicole Nixon, CEO of Five Faces, says the Brisbane-based digital experience and software platform company is helping hospitals make outpatient and perioperative patient journeys easier for both patients and clinicians.
In an interview with the Australian Health Journal filmed at Australasian Institute of Digital Health (AIDH) recent HIC26 conference in Sydney, Nixon explains how Five Faces’ digital front door platform supports patients from the moment an appointment is created, providing information about appointments, preparation, hospital facilities and wayfinding. Patients can also complete digital forms and receive timely notifications, reminders and resources designed to reduce missed or cancelled appointments.
-
Changes in MBS bulk billing incentives address GP capacity in women’s health
Dr. Sneha Wadhwani, a General Practitioner in Bondi, and Conjoint Lecturer at UNSW School of Medicine, is actively involved in enhancing women’s health services across Australia. As the Co-founder and Clinical Director of Evoca Women’s Health, she highlights the significant improvements in funding for women’s health, particularly with the new MBS bulk billing incentives, in new codes, that commenced on November 1, 2025.